https://www.selleckchem.com/pr....oducts/itacitinib-in
CMA can be used as a first-line test for fetuses with increased NT during early pregnancy, with the overall detection rate of pathogenic CNVs being as high as 21.8%. Our results confirmed that NT thickness is correlated with other structural abnormalities and adverse pregnancy outcome, especially for those with NT ≥ 4.5 mm. At the same time, fetuses with other structural abnormalities are at an increased risk for adverse pregnancy outcome. CMA can be used as a first-line test for fetuses with increased NT during early pregn
Like
Comment
Share
